⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Insiders, hedge funds, and politicians trading Humacyte stock (NDAQ:HUMA) in Q1 2024

Published 2024-05-10, 10:25 a/m
© Reuters.  Insiders, hedge funds, and politicians trading Humacyte stock (NDAQ:HUMA) in Q1 2024
HUM
-
BLK
-
CS
-
TWO
-

Quiver Quantitative - $HUMA earnings were just released. Here is a look at recent trades of $HUMA by people who might have an edge.

Congress Members of Congress have disclosed trades of $HUMA stock 5 times in the last quarter. Of those trades, 4 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $HUMA stock by members of Congress: - Senator Tommy Tuberville has traded $HUMA 5 times. They made 4 purchases worth up to $130,000 on 03/21, 02/12 and 1 sale worth up to $15,000 on 01/19.

Company Insiders No recent insider trades of $HUMA on record.

Institutions Here’s a breakdown of some of the largest recent moves of $HUMA stock: - BLACKROCK INC. bought an estimated $1,802,589 of $HUMA stock - CAPSTONE INVESTMENT ADVISORS, LLC bought an estimated $1,412,047 of $HUMA stock - GSA CAPITAL PARTNERS LLP sold an estimated $1,075,904 of $HUMA stock - PRIVATE ADVISOR GROUP, LLC bought an estimated $1,004,090 of $HUMA stock - TWO SIGMA INVESTMENTS, LP bought an estimated $972,134 of $HUMA stock

This article was originally published on Quiver Quantitative

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.